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IntrOductIOn
In type I diabetes mellitus several genetic and epidemiologic factors 
have been recognized. Vitamin D is biologically plausible (it has a role 
in immune regulation).There is some epidemiologic evidence that 
decreased vitamin D level in pregnancy or early childhood may be 
associated with diabetic risk, but the evidence is not yet conclusive 
[1]. Low level of vitamin D has also been shown negative effect in β 
cells function [2,3]. In this study we evaluate glycemic changes after 
vitamin D3 supplement in patients with type I diabetes mellitus and 
vitamin D deficiency. 
MAterIAls And MethOds
Samples are selected among patients with type I diabetes mellitus 
returning to pediatric endocrinology clinic in Taleghani Hospital, 
Gorgan, Iran. The prevalence of vitamin D deficiency in patients 
with type I diabetes mellitus was between 15% to 90.6% [4-6].
Usage of Medcalc software, with a 95% confidence interval 
and 80% power of test, 46 samples are at least required in this 
study. Patients previously had been diagnosed with diabetes 
mellitus criteria including two fasting blood glucose greater 
than 126 mg/dl or DKA presentation at first time. Patients with 
the following criteria were enrolled: older than six months of 
age, less than age of 17, vitamin D levels less than 50 nmol/
lit, lack of secondary diabetes due to other diseases such as 
thalassemia or taking steroids, and lack of neonatal diabetes. 
The exclusion criteria include: irregular intake of vitamin D and 
calcium supplement, abnormal renal function, hypercalciuria with 
nephrolithiasis or nephrocalcinosis. This study was approved by 
the Ethics Committee of Gorgan University of Medical Sciences 
and prior to its beginning. Fifty three patients with type I diabetes 
participated. The baseline demographic characteristics including 
weight, height, BMI, BP, years of diabetes, type of treatment 
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ABstrAct
Background: Glycemic control prevents microvascular 
complications in patients with type I diabetes mellitus such as 
retinopathy, nephropathy and neuropathy that influences quality 
of life. Some studies show the immunomodulatory effect of 
vitamin D in synthesis and secretion of insulin.
Aims: In this study we evaluate glycemic changes after vitamin 
D3 supplement in children with type I diabetes mellitus and 
vitamin D deficiency.
Materials and Methods: In children with type I diabetes mellitus, 
level of vitamin D and HbA1C was measured. Patients with 
type I diabetes mellitus who had vitamin D deficiency (25OHD 
< 50 nmol/lit) treated with 300,000 units of vitamin D3. Calcium 
supplement (40mg/kg/day) divided in two doses in order to avoid 
hungry bone was also used. After three months, 25OHD and 
HbA1C were measured again. Differences, in mean ± SD HbA1C 
and 25OHD were evaluated before and after the study. 
results: Mean ± SD HbA1C was 9.73±1.85 before the study 
which was diminished to 8.55±1.91 after vitamin D3 supplement 
treatment. This decline has a significant difference (p-value < 
0.0001). Mean ± SD 25OHD was 17.33±8.97 nmol/lit before the 
study which is increased to 39.31±14.38 nmol/lit after treatment 
with vitamin D3 supplement. This increase also has a significant 
difference (p-value < 0.0001). Vitamin D3 supplement causes the 
improvement of HbA1C in all groups of glycemic control including 
HbA1C <7.8, 7.8-9.9, and >9.9. This supplement transfer patients 
toward better glycemic control for the entire group (p-value < 
0.0001). 
conclusion: Vitamin D3 supplement improves HbA1C in 
pediatrics with type I diabetes mellitus and vitamin D deficiency.
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including the dose and type of insulin were recorded. HbA1C, 
25OHD, PTH, Ca, P, Mg, Alk-P were performed. 25OHD by the 
method of Eliza with ELIZA READER STATFAX, and HbA1C by 
the method of immunoturbidometry with NYCOCARD, produced 
in Norway were performed. Ca, Mg, P and random urine Ca / Cr 
by AUTO ANALYSER Model Prestige24/I Japan, and PTH by the 
method of chemiluminoscence with SEIMENSE were measured. 
25OHD levels were divided into 3 groups: vitamin D sufficiency 
(25OHD>51nmol/lit), vitamin D insufficiency (25OHD:35-50nmol/
lit), and vitamin D deficiency (25OHD<34.5nmol/lit) [7-10]. HbA1C 
levels were defined based on the control of diabetes, as follows: 
good control (HbA1C<7.8%), fair control (HbA1C:7.8%-9.9%), 
and poor control (HbA1C>9.9%) [7,11]. Patients with vitamin 
D deficiency and vitamin D insufficiency treated with vitamin D 
supplement. Hypovitaminosis was treated with 300,000 IU vitamin 
D3 single dose intramuscular injection [7,8,12,13]. To prevent 
hungry bone due to vitamin D, 40mg/kg/day calcium in 2 divided 
doses was administered [8,12,14,15]. Calcium was continued 
for three months. Insulin dose was recorded by parents in these 
three months. After three months, patients were invited for repeat 
measurements of 25OHD and HbA1C. It is rather likelihood that 
usage of vitamin D can cause hypercalciuria, nephrocalcinosis, 
and nephrolithiasis [9] .Then random samples of urine calcium and 
creatinine were measured at the beginning of the study and after 
12 weeks. If this level was greater than 0.2, renal sonography were 
requested to detect nephrolithiasis, and nephrocalcinosis.
stAtIstIcAl AnAlysIs 
Spss16 software was used for statistical analysis and data 
were described by graphs and tables of numerical index. For 
comparison before and after 25OHD and HbA1C levels, paired 
T-test and Mann-Whitney test were used. According to the number 
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of patients, in order to measure the mean of HbA1C in 3 levels of 
vitamin D adequacy, Kruskal-Wallis test was used. To compare 
the glycemic control of diabetes in 3 groups of vitamin D level, and 
25OHD levels in 3 groups of diabetes control, McNemar test was 
used. The p-value of less than 0.05 was significant. 
results And fIndIngs
In this study 53 patients with type I diabetes were investigated. 3 
cases (5.66%) were vitamin D sufficient. 50 cases (94.3%) were 
vitamin D deficient and vitamin D insufficient, including 3 cases 
(6%) with vitamin D insufficiency and 47 cases (64%) with vitamin D 
deficiency. All of these patients were less than 17-year-old. 
Patients were treated with vitamin D supplement. They were called 
back three months later. 6 patients excluded out of the study since 
2 of them changed their correspondent address, and the other 4 
refused their cooperation. The above mentioned cases were vitamin 
D deficient and had fair control. 
Finally we had 44 patients for analysis, 21 cases (47.7%) were 
female and 23 cases (52.3%) were male. None of them previously 
had hypertension and proteinuria. A 16-year-old female patient 
with poor control HbA1C and vitamin D deficiency, suffered from 
retinopathy. Duration of diabetes mean ±SD was 3.62±2.18, 
between 6 months and 10 years.
27 patients (61.36%) used NPH/Regular insulin, and 17 (38.64%) 
used Glargine/Aspart insulin. From familial history point of view; 
27(61.27%) had negative past history and 17(38.73%) had a positive 
history for two type of diabetes in their close sanguinity.
Mean ±SD HbA1C was 9.73±1.85 before the study which was 
diminished to 8.55±1.91 after vitamin D3 supplement treatment. 
This decline has a significant difference (p-value < 0.0001). Mean ± 
SD HbA1C was evaluated between groups of 25OHD [Table/Fig-1], 
separately with paired T-test. Decreasing in this parameter has a 
significant difference in vitamin D deficient group (p-value < 0.0001). 
By the usage of Mann-Whitney test had a non-significant difference 
in vitamin D insufficient group. 
 
25ohd level
X±Sd hba1C
number Before Study after Study P-value
Vitamin D deficiency 41 1.89 ±9.68 1.97 ±8.50 <0.0001
Vitamin D insufficiency 3 1.04 ±10.47 0.72 ±9.20 NS
Total 44 1.85 ±9.73 1.91 ±8.55 <0.0001
[table/fig-1]: Mean ± SD HbA1C in sub groups of 25OHD level
Before the interference, the glycemic control of patients in good, 
fair, and poor control were 6 (13.6%), 21 (47.7%), and 17(38.6%) 
respectively. After interference, the statistics changed respectively 
to 15(34.1%), 19(43.2%), and 10(22.7%). By McNemar test, 
these differences were significant) p-value<0.0001). Vitamin D3 
supplement causes the improvement of HbA1C in all groups of 
glycemic control including HbA1C <7.8, 7.8-9.9, and >9.9. This 
supplement transfers patients toward better glycemic control in all 
groups (p-value < 0.0001) [Table/Fig-2]. Mean ± SD 25OHD was 
17.33±8.97 nmol/lit before the study which is increased to 39.31 
±14.38 nmol/lit after treatment with vitamin D3 supplement. This 
increase also has a significant difference (p-value < 0.0001).
The changed adequacy of vitamin D based on 25OHD were 
41(93.2%) vitamin D deficient and 3(6.8%) vitamin D insufficient 
before interference, then 15 (34.1%) vitamin D deficient, 21(47.7%) 
vitamin D insufficient, and 5(18.2%) vitamin D sufficient after 
interference [Table/Fig-3]. After intervention, the relative frequency 
of vitamin D deficiency and insufficiency was 81.8%. Insulin 
requirement for each patient was not changed during study and pre 
and post vitamin D supplement.
Calcium, phosphorus, magnesium, and PTH were in the normal 
range. By Kruskal-Wallis test, mean for them were not different 
according to age and sex (p-value>0.05).
Hypercalciuria were defined with random Calcium/Creatinin 
ratio>0.2 in patients older than 2 y [16]. Before the study, 4 
cases, then after the study another 3 cases (not previous cases) 
had hypercalciuria, normal renal sonography without dysuria and 
indication for treatment. We recommended them to follow up.
dIscussIOn
In this study, it is shown that treatment with vitamin D3 causes better 
glycemic control in patients with type I diabetes mellitus. Moreover, 
vitamin D3 supplement causes the improvement of HbA1C in all 
groups of glycemic control including poor, fair and good. Increased 
level of 25OHD in all groups including sufficiency, deficiency and 
insufficiency of vitamin D was observed. According to mentioned 
numbers in previous studies, relative frequency of 94.3% (before 
supplement) in patients with type I diabetes, was expected. Gorgan 
has a rainy weather in most seasons of the year and climate has a 
significant role in this statistic. El Baba et al., showed lower level of 
25OHD in patients with type I diabetes at the end of cloudy season 
[17]. In Aljabri study, more level of 25OHD with better glycemic 
control was observed [7]. In our study, reduction in mean HbA1C 
[table/fig-2]: Comparison of glycemic control in patients with type I diabetes and 
vitamin D deficiency before and after interference
[table/fig-3]: Comparison of 25OHD level in patients with type I diabetes and 
vitamin D deficiency before and after interference
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among vitamin D deficient group was statistically significant. It is 
notable we had only 44 children with type I diabetes and in Aljabri’s 
study 88 children and adults had been participated. In both of 
them, the effect of vitamin D on glycemic control had no differences 
according to age and sex.
The Thraikill et al., recognized vitamin D deficiency or insufficiency 
is slightly more prevalent in diabetic patients with microalbuminuria, 
especially with the increase in urinary vitamin D Binding protein 
excretion [18]. Attended children were already checked for 
microalbuminuria and had no problem. The Kaur et al., showed 
higher percentage of retinopathy in vitamin D deficient patients [19]. 
In this study we had a 16-year-old female with retinopathy which 
had poor control condition. Her sibling had no changes in HbA1C 
and 25OHD regardless of using similar supplement of other patients. 
Low level of vitamin D causes inflammatory process and increases 
microvascular complications [20].
Two studies in Iran suggest polymorphism of vitamin D receptor 
genes in type I diabetes mellitus [21,22]. In our study positive 
family history for two types of diabetes were 38.73% and changes 
in HbA1C and 25OHD did not differ in relatives and non- relatives 
(p-value>0.05). In another study, bidirectional relation between 
diabetes and vitamin D deficiency was expressed [18], and Borkar 
showed 86 percent of recent onset diabetic patients were vitamin 
D deficient [23]. Also, we had vitamin D deficiency in recent onset 
patients with diabetes.
Bizzarri’s study was not confirmed calcitriol protective effect on β cells 
function in recent onset diabetes [24]. Unlike that study, treatment 
response in our results did not differ in involvement duration group 
including <2 y and ≥2 y (p-value>0.05).
Our study was limited by number of patients and changes in 
address and telephone number. We need another study to follow 
our patients and possible changes in insulin requirement. Based on 
high incidence of vitamin D deficiency in patients with type I diabetes 
mellitus, we recommend serious treatment of this subject. It seems 
that when we encounter healthy patients with vitamin D deficiency, 
their family has also investigated for similar condition, especially when 
they have risk factor for diabetes. According to relation between 
retinopathy and vitamin D deficiency in Devaraj study, we propose 
early evaluation of vitamin D level in newly diagnosed children, and 
when the patient is vitamin D deficient, ophthalmologic checkup will 
be performed earlier and more frequent. 
Finally, we offer patients with diabetes and vitamin D deficiency the 
daily dosage of 400 to 1000 IU of vitamin D [25], and maintenance 
dose of 3.5-9 gr / m2 elemental calcium [12]. Family member of 
patients with vitamin D deficiency, was also vitamin D deficient [8]. 
We recommend diagnostic evaluation in their family and treatment 
if needed.
cOnclusIOn
Vitamin D3 supplement improves HbA1C in patients with type I 
diabetes and vitamin D deficiency.
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